Correction
for
Jho et al., Circ Res 96 (12) 1282-1290.
Circulation Research. 2009;104:e58
doi: 10.1161/CIRCRESAHA.109.100004
(Circulation Research. 2009;104:e58.)
© 2009 American Heart Association, Inc.
Correction
In the article by Jho et al, published in the June 2005 issue
of the journal (
Circ Res. 2005;96:1282–1290), Figure 4A
and 4C are incorrect. The correct
figure is published here,
which shows the same result as the previously published Figure
4A and 4C. The corrected figure does not alter the conclusions
of the article. The corrected
figure and legend appear below,
and the corrected article can be found online at http://circres.ahajournals.org/cgi/content/full/96/12/1282.

View larger version (13K):
[in this window]
[in a new window]
|
Figure 4. Angiopoietin I inhibits the inward Ca2+ current induced by extracellular application of VEGF and intracellular application of IP3. A, Continuous recording of VEGF-induced current at the holding potential (–50 mV). After establishing whole-cell patch-clamp configuration, VEGF (1 µg/mL) was added to the extracellular milieu. C, Internally applied IP3 elicited store-operated inward current in a cell voltage clamped to –50 mV. A and C, La3+ (1 mmol/L) was added to the bath solution where indicated to block the current.
|
|
The authors regret the error.
Reference
1. Jho D, Mehta D, Ahmmed G, Gao X-P, Tiruppathi C, Broman M, Malik AB: Angiopoietin-1 opposes VEGF-induced increase in endothelial permeability by inhibiting TRPC1-dependent Ca2 influx. Circ Res. 2005;96:1282–1290.